Tao received her Ph.D. in Analytical Chemistry from University of Florida in 2013. Her doctoral study under professor Weihong Tan explored the applications of aptamer-conjugated nanomaterials in cancer diagnostics and therapy. She then joined Small Molecule Pharmaceutical Sciences in Genentech, Inc. in 2014, where she has contributed to various projects ranging from antibody-drug conjugates to peptides and traditional small molecule drugs, with research interests in developing novel analytical and chromatographic techniques for characterization of new drug modalities.
Dr. Weng is Scientific Director, Janssen Fellow, and Head of East Coast Bioanalytical Chemistry and Pharmacokinetics, Janssen Research & Development, Johnson and Johnson, Spring House, PA, USA. In addition to support various programs at Janssen, current research interests of his group include novel bioanalytical quantitation for biomarkers, protein/peptides, and novel drug conjugates and unique formulations. Dr. Weng has over 100 peer-reviewed journal publications,
Dr. Perry G. Wang is a chemist in the Office of Regulatory Science, US Food and Drug Administration (US FDA). His interests include analytical method development and validation for drugs and constituents of foods and cosmetic products using advanced instrumentation. His expertise focuses on high throughput drug analysis by LC/MS/MS. His current research focuses on developing analytical methods for constituents in cosmetics and dietary supplements by GC/MS/MS and LC/MS/MS.
Dr. Yi He studied applied chemistry and environmental chemical engineering at Shanghai Jiao Tong University in China and analytical chemistry in National University of Singapore (NUS) before completing her Ph.D. in analytical chemistry in 2004 at the City University of New York (CUNY). She took a position as an Assistant Professorof Chemistry at John Jay College of Criminal Justice of CUNY in fall 2004 and was promoted to full professor in 2016.
Michael W. Dong, PhD. Born in Shanghai and raised in Hong Kong, Michael is a principal consultant at MWD Consulting (www.mwd-consulting.com). He was formerly senior scientist at Genentech, Small Molecule Analytical Chemistry and QC, research director at Synomics Pharma (CRO), research fellow at Purdue Pharma, and senior staff scientist at Applied Biosystems / Perkin-Elmer. He holds a PhD in Analytical Chemistry from City University of New York and a certificate in Biotechnology
Dr. Emmi Zheng received her B.S. in chemistry from Jilin University, and Ph.D. in analytical chemistry from Dr. David Hage’s research group at the University of Nebraska-Lincoln (UNL). Emmi is currently an R&D Scientist in the biotherapeutics product development group at Smith & Nephew. Emmi has ten year research experience in bioanalytical chemistry.
Dr. Fengjian Shi is a scientist in Analytical Development at Biogen. Prior to joining Biogen, Fengjian received his B.S. in Chemistry from Nanjing University in 2011 and PhD in Analytical Chemistry from Temple University in 2017.
College: Yale University, 1973
M.S.: U. of Nebraska Medical Center (Biochemistry, 1977).
Ph.D.: Purdue U. (Biochemistry, 1980). Advisor: Fred Regnier. Thesis work: Development of HPLC packing materials and techniques for protein applications.
Dr. Baomin Xin, Senior VP of DMPK & Bioanalytical Services department at Pharmalegacy, obtained his PhD under Professor Milton L Lee at Brigham Young University (BYU). During his PhD research, he was one of the chief designers who design and built an orthogonal extraction time-of-flight mass spectrometer. He designed, and made the mechanical drawings of, the inlet assembly, including the main flange, RF-only quadrupole focusing lens set, inter-quad lens, DC/RF quads set, and exit slit. Outstanding
Mingming Ma is the Principal Research Scientist in Crop Protection Regulatory Sciences, Corteva Agriscience. She has more than 15 years experiences in analytical and bioanalytical chemistry for both small and large molecules. She has 26 peer-reviewed journal publications and co-edited a book. Dr. Ma serves as an American Chemical Society - AGRO division executive committee since 2019.
Howard (HongYue) Guo
Dr. Hongyue (Howard) Guo is a senior scientist in Drug Product Development at BMS. Prior to joining BMS, Howard has worked as an investigator in CMC analytical at GSK. Howard received Ph.D. degree in Analytical Chemistry from The University of Texas at Arlington in 2016.